LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Home・Akciju saraksts・Schrodinger Inc

Schrodinger Inc

Slēgts

SektorsVeselības aprūpe

12.69 -2.16

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

12.49

Max

13.13

Galvenie mērījumi
By Trading Economics
Ienākumi	169M 136M
Pārdošana	33M 87M
EPS	-0.18
Peļņas marža	155.644
Darbinieki	850
EBITDA	67M 36M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+68.84% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 6. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	69M 895M
Iepriekšējā atvēršanas cena	14.85
Iepriekšējā slēgšanas cena	12.69

Ziņu noskaņojums

By Acuity

77%

23%

323 / 351 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

23.27 / 26.13 Atbalsts un pretestība

Schrodinger Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 5. marts 23:01 UTC

Peļņas

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

2026. g. 5. marts 21:54 UTC

Peļņas

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

2026. g. 5. marts 21:35 UTC

Galvenie tirgus virzītāji

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

2026. g. 6. marts 00:00 UTC

Galvenie ziņu notikumi

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

2026. g. 5. marts 23:46 UTC

Tirgus saruna

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

2026. g. 5. marts 23:33 UTC

Tirgus saruna

Gold Edges Higher on Possible Technical Recovery -- Market Talk

2026. g. 5. marts 23:27 UTC

Tirgus saruna

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

2026. g. 5. marts 22:54 UTC

Tirgus saruna

Peļņas

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

2026. g. 5. marts 22:50 UTC

Tirgus saruna

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

2026. g. 5. marts 22:48 UTC

Peļņas

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026. g. 5. marts 22:46 UTC

Peļņas

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

2026. g. 5. marts 22:44 UTC

Peļņas

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026. g. 5. marts 21:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 5. marts 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 5. marts 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 5. marts 21:35 UTC

Peļņas

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026. g. 5. marts 21:32 UTC

Peļņas

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

2026. g. 5. marts 21:26 UTC

Peļņas

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

2026. g. 5. marts 21:24 UTC

Peļņas

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

2026. g. 5. marts 21:23 UTC

Peļņas

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

2026. g. 5. marts 21:22 UTC

Peļņas

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026. g. 5. marts 21:21 UTC

Peļņas

Costco February Digitally-Enabled Sales Rose 21.8% >COST

2026. g. 5. marts 21:21 UTC

Peļņas

Costco Total Co Comparable Sales for February Rose 7.9% >COST

2026. g. 5. marts 21:20 UTC

Peļņas

Costco February Net Sales Were $21.69 B >COST

2026. g. 5. marts 21:20 UTC

Peļņas

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

2026. g. 5. marts 21:20 UTC

Peļņas

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

2026. g. 5. marts 21:19 UTC

Peļņas

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

2026. g. 5. marts 21:18 UTC

Peļņas

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

2026. g. 5. marts 21:18 UTC

Peļņas

Costco 2Q Same-Store Sales Up 7.4% >COST

2026. g. 5. marts 21:15 UTC

Peļņas

Costco 2Q EPS $4.58 >COST

Salīdzinājums

Cenas izmaiņa

Schrodinger Inc Prognoze

Cenas mērķis

By TipRanks

68.84% augšup

Prognoze 12 mēnešiem

Vidējais 22 USD 68.84%

Augstākais 30 USD

Zemākais 18 USD

Pamatojoties uz 6 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Schrodinger Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

6 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 6 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Schrodinger Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

23.27 / 26.13Atbalsts un pretestība

Recent bearish events outweigh bullish events.

All events are bullish.

Noskaņojums

By Acuity

323 / 351 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.